Viscoelastic interactions between polydeoxyribonucleotide and ophthalmic excipients

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Drug Development and Industrial Pharmacy

• Publication date

  2016-02-01

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.3109/03639045.2015.1040417PMID 26023993
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of textured eye drop bottles on the photostability of pranoprofen 0.1% ophthalmic solution

  2015cited by this paper
• Surface relaxations as a tool to distinguish the dynamic interfacial properties of films formed by normal and diseased meibomian lipids.

  2014cited by this paper
• In situ gelling systems: a strategy to improve the bioavailability of ophthalmic pharmaceutical formulations.

  2014cited by this paper
• Ultrasound‐guided Prolotherapy with Polydeoxyribonucleotide Sodium in Ischiofemoral Impingement Syndrome

  2014cited by this paper
• Effects of Polydeoxyribonucleotide in the Treatment of Pressure Ulcers

  2014cited by this paper
• Thermoresponsive ophthalmic poloxamer/tween/carbopol in situ gels of a poorly water-soluble drug fluconazole: preparation and in vitro–in vivo evaluation

  2014cited by this paper
• Influence of interfacial rheology on drainage from curved surfaces.

  2014cited by this paper
• Protective effects of polydeoxyribonucleotides on cartilage degradation in experimental cultures

  2013cited by this paper
• Recent advances in ocular drug delivery

  2013cited by this paper
• The Effects of Polydeoxyribonucleotide on the Survival of Random Pattern Skin Flaps in Rats

  2013cited by this paper
• Preservative toxicity in glaucoma medication: clinical evaluation of benzalkonium chloride-free 0.5% timolol eye drops

  2013cited by this paper
• Activation of adenosine A2A receptors restores the altered cell-cycle machinery during impaired wound healing in genetically diabetic mice.

  2011cited by this paper
• Polydeoxyribonucleotide reduces cytokine production and the severity of collagen-induced arthritis by stimulation of adenosine A(₂A) receptor.

  2011cited by this paper
• Interaction of cationic surfactants with DNA detected by spectroscopic and acoustic wave techniques.

  2010cited by this paper
• Nanomedicines for ocular NSAIDs: safety on drug delivery.

  2009cited by this paper
• Adenosine receptor agonists for promotion of dermal wound healing.

  2009cited by this paper
• Ophthalmic formulations of the intraocular hypotensive melatonin agent 5-MCA-NAT.

  2009cited by this paper
• Polydeoxyribonucleotide stimulates angiogenesis and wound healing in the genetically diabetic mouse

  2008cited by this paper
• Similarities and differences in interaction of K+ and Na+ with condensed ordered DNA. A molecular dynamics computer simulation study

  2006cited by this paper
• Electrostatic, steric, and hydration interactions favor Na(+) condensation around DNA compared with K(+).

  2006cited by this paper
• Na+ shows a markedly higher potential than K+ in DNA compaction in a crowded environment.

  2005cited by this paper
• Clinical Evaluation of Corneal Epithelialization after Photorefractive Keratectomy in Patients Treated with Polydeoxyribonucleotide (PDRN) Eye Drops: A Randomized, Double-blind, Placebo-controlled Trial

  2004cited by this paper
• Polydeoxyribonucleotide (PDRN) promotes human osteoblast proliferation: a new proposal for bone tissue repair.

  2003cited by this paper
• Evaluation of the stability of polymer-based plasmid DNA delivery systems after ultrasound exposure.

  2003cited by this paper
• In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate.

  2002cited by this paper
• On the competition between water, sodium ions, and spermine in binding to DNA: a molecular dynamics computer simulation study.

  2002cited by this paper
• Formulation aspects in the development of osmotically controlled oral drug delivery systems.

  2002cited by this paper
• Clinical Evaluation of the Trophic Effect of Polydeoxyribonucleotide (PDRN) in Patients Undergoing Skin Explants. A Pilot Study

  2001cited by this paper
• Water quantitatively induces the mucoadhesion of liquid crystalline phases of glyceryl monooleate

  2001cited by this paper
• Comparison of Hypotonic and Isotonic Solutions Containing Sodium Hyaluronate on the Symptomatic Treatment of Dry Eye Patients

  2001cited by this paper
• Effect of ethanol on structural transitions of DNA and polyphosphates under Ca2+ ions action in mixed solutions.

  2000cited by this paper
• Carbopol/pluronic phase change solutions for ophthalmic drug delivery.

  2000cited by this paper
• Evaluation of pluronic F127-based sustained-release ocular delivery systems for pilocarpine using the albino rabbit eye model.

  1998cited by this paper
• Linear viscoelastic moduli of concentrated DNA solutions

  1998cited by this paper
• DNA condensation.

  1996cited by this paper
• Characterization and quantitation of the active polynucleotide fraction (PDRN) from human placenta, a tissue repair stimulating agent.

  1996cited by this paper
• Influence of both salvage and DNA damage response pathways on resistance to chemotherapeutic antimetabolites.

  1996cited by this paper
• Multimolecular aggregation in concentrated isotropic solutions of mononucleosomal DNA in 1 M sodium chloride

  1994cited by this paper
• Purine salvage as a metabolite and energy saving mechanism in the ocular lens.

  1992cited by this paper
• Irritation associated with tear-replacement ophthalmic drops. A pharmaceutical and subjective investigation.

  1989cited by this paper
• Irritation associated with tear-replacement ophthalmic drops. A pharmaceutical and subjective investigation.

  1989cited by this paper

• Multifunctional Role of Polyvinylpyrrolidone in Pharmaceutical Formulations

  2021cites this paper
• Physicochemical evaluation and pharmacodynamics of itraconazole-loaded liquid crystal precursor for vaginal delivery

  2021cites this paper
• Double controlled release of highly insoluble cilostazol using surfactant‐driven pH dependent and pH‐independent polymeric blends and in vivo bioavailability in beagle dogs

  2019cites this paper
• Pharmacological Activity and Clinical Use of PDRN

  2017cites this paper
• Polydeoxyribonucleotide Injection in the Treatment of Chronic Supraspinatus Tendinopathy: A Case-Controlled, Retrospective, Comparative Study With 6-Month Follow-Up.

  2017cites this paper